Meet with our Team Members
About our Cell Therapy & Viral Vector Gene Therapy Services
We develop and manufacture diverse cell therapies including CD34+ hematopoietic stem cells, autologous and allogenic T-cells, and NK cells. Our cell therapy capabilities cover numerous technologies, ranging from closed to open systems at different scales, depending on client needs. We also develop and manufacture adeno-associated viral vectors, lenti viral vectors and retro viral vectors. Our ready-to-use platform capabilities are built on cell factories (up to 48L) and bioreactors (up to 200L) using adherent processes, designed entirely in-house.
About the Event
At Advanced Therapies 2022, we will be exploring the hottest topics in the ATMP space alongside a faculty of industry leading speakers. All whilst showcasing the latest technologies and advancements in the industry. Join us IN-PERSON in May 2022.